199 related articles for article (PubMed ID: 19149411)
1. Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.
Wall JS; Richey T; Allen A; Donnell R; Kennel SJ; Solomon A
Comp Med; 2008 Dec; 58(6):542-50. PubMed ID: 19149411
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse model of AA amyloidosis.
Solomon A; Weiss DT; Schell M; Hrncic R; Murphy CL; Wall J; McGavin MD; Pan HJ; Kabalka GW; Paulus MJ
Am J Pathol; 1999 Apr; 154(4):1267-72. PubMed ID: 10233864
[TBL] [Abstract][Full Text] [Related]
3. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A
Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.
Kennel SJ; Stuckey A; McWilliams-Koeppen HP; Richey T; Wall JS
Mol Imaging Biol; 2016 Aug; 18(4):483-9. PubMed ID: 26573301
[TBL] [Abstract][Full Text] [Related]
5. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
[TBL] [Abstract][Full Text] [Related]
6. Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.
Kennel SJ; Macy S; Wooliver C; Huang Y; Richey T; Heidel E; Wall JS
Amyloid; 2014 Mar; 21(1):45-53. PubMed ID: 24446872
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis.
Ray A; Shakya A; Kumar D; Benson MD; Ray BK
J Immunol; 2006 Aug; 177(4):2601-9. PubMed ID: 16888022
[TBL] [Abstract][Full Text] [Related]
8. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.
Wall JS; Richey T; Stuckey A; Donnell R; Macy S; Martin EB; Williams A; Higuchi K; Kennel SJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E586-94. PubMed ID: 21807994
[TBL] [Abstract][Full Text] [Related]
9. Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.
Wall JS; Williams A; Richey T; Stuckey A; Wooliver C; Christopher Scott J; Donnell R; Martin EB; Kennel SJ
Mol Imaging Biol; 2017 Oct; 19(5):714-722. PubMed ID: 28229334
[TBL] [Abstract][Full Text] [Related]
10. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Unique Amyloid Sequence in AA Amyloidosis of a Pig Associated With Streptococcus Suis Infection.
Kamiie J; Sugahara G; Yoshimoto S; Aihara N; Mineshige T; Uetsuka K; Shirota K
Vet Pathol; 2017 Jan; 54(1):111-118. PubMed ID: 27520112
[TBL] [Abstract][Full Text] [Related]
12. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A.
Lin X; Watanabe K; Kuragano M; Tokuraku K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494290
[TBL] [Abstract][Full Text] [Related]
15. Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice.
Maeda M; Murakami T; Muhammad N; Inoshima Y; Ishiguro N
Exp Anim; 2016 Nov; 65(4):427-436. PubMed ID: 27321428
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
17. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic mechanisms of amyloid A amyloidosis.
Simons JP; Al-Shawi R; Ellmerich S; Speck I; Aslam S; Hutchinson WL; Mangione PP; Disterer P; Gilbertson JA; Hunt T; Millar DJ; Minogue S; Bodin K; Pepys MB; Hawkins PN
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16115-20. PubMed ID: 23959890
[TBL] [Abstract][Full Text] [Related]
19. Experimental transmission of AA amyloidosis by injecting the AA amyloid protein into interleukin-1 receptor antagonist knockout (IL-1raKO) mice.
Watanabe K; Uchida K; Chambers JK; Tei M; Shoji A; Ushio N; Nakayama H
Vet Pathol; 2015 May; 52(3):505-12. PubMed ID: 25391376
[TBL] [Abstract][Full Text] [Related]
20. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
